The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
European Surveillance of Antimicrobial Consumption (ESAC): outpatient antibiotic use in Europe
Abstract
BACKGROUND: Data on more than a decade of outpatient quinolone use were collected from 33 European countries within the European Surveillance of Antimicrobial Consumption (ESAC) project, funded by the European Centre for Disease Prevention and Control (ECDC). METHODS: For the period 1997-2009, data on outpatient use of systemic quinolones aggregated at the level of the active substance were collected using the Anatomical Therapeutic Chemical (ATC)/defined daily dose (DDD) method (WHO, version 2011), and expressed in DDD and packages per 1000 inhabitants per day (DID and PID, respectively). Using a classification based on pharmacokinetic and in vitro potency profiles, quinolone use was analysed with regard to trends over time, seasonal variation and composition. RESULTS: Total outpatient quinolone use in 2009 varied by a factor of 7.5 between the country with the highest (Italy, 3.61 DID) and the country with the lowest (the UK, 0.48 DID) quinolone use. The second-generation quinolones accounted for >50% of quinolone use (mainly ciprofloxacin), except for Croatia, where first-generation quinolones (mainly norfloxacin) were mostly used. A significant increase in outpatient quinolone use was found for Europe, as well as a large seasonal variation, which increased significantly over time from 1997 to 2009. Relative use of third-generation quinolones significantly increased over time with respect to the use of second-generation quinolones, while the relative use of both significantly increased with respect to the first-generation quinolones. Levofloxacin and moxifloxacin (respiratory quinolones) represented >10% of quinolone outpatient use in 17 countries, with extreme seasonal variation in all countries. CONCLUSIONS: There was a substantial increase and change in the pattern of quinolone use between 1997 and 2009, a period during which quinolones that are effective for the treatment of respiratory tract infections were introduced. These quinolones are not the first-line antibiotics for this indication and their use should generally be limited, and quinolones should ideally show no substantial seasonal variation in terms of their use.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Outpatient antibiotic use in Europe and association with resistance: a cross-national database study
Goossens, H., Ferech, M., Vander Stichele, R., & Elseviers, M. (2005) · The Lancet · doi:10.1016/s0140-6736(05)17907-0 · Cited by 3,359
Self-citationGuidelines for the management of adult lower respiratory tract infections
Woodhead, M., Blasi, F., Ewig, S., Huchon, G., Leven, M., Ortqvist, A., Schaberg, T., Torres, A., van der Heijden, G., & Verheij, T. J. M. (2005) · European Respiratory Journal · doi:10.1183/09031936.05.00055705 · Cited by 895
WHO Regional Office for Europe
Tsechkovski, M. (1993) · The Lancet · doi:10.1016/0140-6736(93)91122-3 · Cited by 871
Variation in antibiotic use in the European Union
Cars, O., Mölstad, S., & Melander, A. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04972-2 · Cited by 698
Antimicrobial Drug Use and Resistance in Europe
van de Sande-Bruinsma, N., Grundmann, H., Verloo, D., Tiemersma, E., Monen, J., Goossens, H., Ferech, M., & the European Antimicrobial Resistance Surveillance System and European Surveillance of Antimicrobial Consumption Project Groups (2008) · Emerging Infectious Diseases · doi:10.3201/eid1411.070467 · Cited by 485
Self-citationGuidelines for the management of adult lower respiratory tract infections - Summary
Woodhead, M., Blasi, F., Ewig, S., Garau, J., Huchon, G., Ieven, M., Ortqvist, A., Schaberg, T., Torres, A., van der Heijden, G., et al. (2011) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2011.03602.x · Cited by 468
Fluoroquinolone resistance among Gram-positive cocci
Hooper, D. C. (2002) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(02)00369-9 · Cited by 320
Adriaenssens, N., Coenen, S., Tonkin-Crine, S., Verheij, T. J. M., Little, P., & Goossens, H. (2011) · BMJ Quality & Safety · doi:10.1136/bmjqs.2010.049049 · Cited by 309
Self-citationQuinolone generations: natural history or natural selection?
Ball, P. (2000) · Journal of Antimicrobial Chemotherapy · doi:10.1093/oxfordjournals.jac.a020889 · Cited by 302
Coenen, S., Ferech, M., Haaijer-Ruskamp, F. M., Butler, C. C., Vander Stichele, R. H., Verheij, T. J. M., Monnet, D. L., Little, P., Goossens, H., & the ESAC Project Group (2007) · Quality and Safety in Health Care · doi:10.1136/qshc.2006.021121 · Cited by 245
Self-citation
Cited by
Zhang, Q.-Q., Ying, G.-G., Pan, C.-G., Liu, Y.-S., & Zhao, J.-L. (2015) · Environmental Science & Technology · doi:10.1021/acs.est.5b00729 · Cited by 3,852
Global antibiotic consumption 2000 to 2010: an analysis of national pharmaceutical sales data
Van Boeckel, T. P., Gandra, S., Ashok, A., Caudron, Q., Grenfell, B. T., Levin, S. A., & Laxminarayan, R. (2014) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(14)70780-7 · Cited by 2,280
Costelloe, C., Metcalfe, C., Lovering, A., Mant, D., & Hay, A. D. (2010) · BMJ · doi:10.1136/bmj.c2096 · Cited by 1,981
Environmental pollution by antibiotics and by antibiotic resistance determinants
Martinez, J. L. (2009) · Environmental Pollution · doi:10.1016/j.envpol.2009.05.051 · Cited by 1,912
Degradation and removal methods of antibiotics from aqueous matrices – A review
Homem, V., & Santos, L. (2011) · Journal of Environmental Management · doi:10.1016/j.jenvman.2011.05.023 · Cited by 1,521
Access to effective antimicrobials: a worldwide challenge
Laxminarayan, R., Matsoso, P., Pant, S., Brower, C., Røttingen, J.-A., Klugman, K., & Davies, S. (2016) · The Lancet · doi:10.1016/s0140-6736(15)00474-2 · Cited by 1,465
Wellington, E. M., Boxall, A. B., Cross, P., Feil, E. J., Gaze, W. H., Hawkey, P. M., Johnson-Rollings, A. S., Jones, D. L., Lee, N. M., Otten, W., et al. (2013) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(12)70317-1 · Cited by 1,122
Megraud, F., Coenen, S., Versporten, A., Kist, M., Lopez-Brea, M., Hirschl, A. M., Andersen, L. P., Goossens, H., Glupczynski, Y., & on behalf of the Study Group participants (2013) · Gut · doi:10.1136/gutjnl-2012-302254 · Cited by 839
Self-citationFluoroquinolone antibiotics: An emerging class of environmental micropollutants
Van Doorslaer, X., Dewulf, J., Van Langenhove, H., & Demeestere, K. (2014) · Science of The Total Environment · doi:10.1016/j.scitotenv.2014.08.075 · Cited by 819
Impact of antibiotics on the human microbiome and consequences for host health
Patangia, D. V., Anthony Ryan, C., Dempsey, E., Paul Ross, R., & Stanton, C. (2022) · MicrobiologyOpen · doi:10.1002/mbo3.1260 · Cited by 754
Detection and fate of antibiotic resistant bacteria in wastewater treatment plants: A review
Bouki, C., Venieri, D., & Diamadopoulos, E. (2013) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2013.01.016 · Cited by 664
Small intestinal bacterial overgrowth in patients with irritable bowel syndrome
Posserud, I., Stotzer, P.-O., Björnsson, E. S., Abrahamsson, H., & Simrén, M. (2007) · Gut · doi:10.1136/gut.2006.108712 · Cited by 499
Antimicrobial Drug Use and Resistance in Europe
van de Sande-Bruinsma, N., Grundmann, H., Verloo, D., Tiemersma, E., Monen, J., Goossens, H., Ferech, M., & the European Antimicrobial Resistance Surveillance System and European Surveillance of Antimicrobial Consumption Project Groups (2008) · Emerging Infectious Diseases · doi:10.3201/eid1411.070467 · Cited by 485
Self-citationHays, K. E., Pfaffinger, J. M., & Ryznar, R. (2024) · Gut Microbes · doi:10.1080/19490976.2024.2393270 · Cited by 453
The genetic basis of the fitness costs of antimicrobial resistance: a meta‐analysis approach
Vogwill, T., & MacLean, R. C. (2015) · Evolutionary Applications · doi:10.1111/eva.12202 · Cited by 443
Aarestrup, F. M. (2015) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2014.0085 · Cited by 298
Megraud, F., Bruyndonckx, R., Coenen, S., Wittkop, L., Huang, T.-D., Hoebeke, M., Bénéjat, L., Lehours, P., Goossens, H., & Glupczynski, Y. (2021) · Gut · doi:10.1136/gutjnl-2021-324032 · Cited by 291
Self-citationVersporten, A., Bolokhovets, G., Ghazaryan, L., Abilova, V., Pyshnik, G., Spasojevic, T., Korinteli, I., Raka, L., Kambaralieva, B., Cizmovic, L., et al. (2014) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(14)70071-4 · Cited by 290
Self-citationHow to educate prescribers in antimicrobial stewardship practices
Pulcini, C., & Gyssens, I. C. (2013) · Virulence · doi:10.4161/viru.23706 · Cited by 286
Ebert, I., Bachmann, J., Kühnen, U., Küster, A., Kussatz, C., Maletzki, D., & Schlüter, C. (2011) · Environmental Toxicology and Chemistry · doi:10.1002/etc.678 · Cited by 281
on behalf of the ESAC Project Group, Adriaenssens, N., Coenen, S., Versporten, A., Muller, A., Minalu, G., Faes, C., Vankerckhoven, V., Aerts, M., Hens, N., et al. (2011) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkr453 · Cited by 258
Self-citationA survey of public knowledge and awareness related to antibiotic use and resistance in Sweden
André, M., Vernby, Å., Berg, J., & Lundborg, C. S. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq104 · Cited by 256
Romano, A., Gaeta, F., Valluzzi, R. L., Caruso, C., Rumi, G., & Bousquet, P. J. (2010) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2010.06.052 · Cited by 162
Impact of Over-the-Counter Restrictions on Antibiotic Consumption in Brazil and Mexico
Santa-Ana-Tellez, Y., Mantel-Teeuwisse, A. K., Dreser, A., Leufkens, H. G. M., & Wirtz, V. J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0075550 · Cited by 135
“High seasonal fluctuations in antibiotics consumption suggest inadequate use for viral acute respiratory tract infections (ARI) [23].”
BackgroundLöffler, C., & Böhmer, F. (2017) · PLoS ONE · doi:10.1371/journal.pone.0188061 · Cited by 75
GPs' views in five European countries of interventions to promote prudent antibiotic use
Tonkin-Crine, S., Yardley, L., Coenen, S., Fernandez-Vandellos, P., Krawczyk, J., Touboul, P., Verheij, T., & Little, P. (2011) · British Journal of General Practice · doi:10.3399/bjgp11x572445 · Cited by 49
Self-citationNaughton, C., Feely, J., & Bennett, K. (2009) · Journal of Evaluation in Clinical Practice · doi:10.1111/j.1365-2753.2008.01099.x · Cited by 49
Antibiotic prescribing patterns in out-of-hours primary care: A population-based descriptive study
Huibers, L., Moth, G., Christensen, M. B., & Vedsted, P. (2014) · Scandinavian Journal of Primary Health Care · doi:10.3109/02813432.2014.972067 · Cited by 43
Stanisavljević, S., Čepić, A., Bojić, S., Veljović, K., Mihajlović, S., Đedović, N., Jevtić, B., Momčilović, M., Lazarević, M., Mostarica Stojković, M., et al. (2019) · Scientific Reports · doi:10.1038/s41598-018-37505-7 · Cited by 43
Metadata
- Authors
- Ferech, M., Coenen, S., Malhotra-Kumar, S., Dvorakova, K., Hendrickx, E., Suetens, C., & Goossens, H.
- Venue
- Journal of Antimicrobial Chemotherapy
- Publisher
- Oxford University Press (OUP)
- Published
- 2006-05-30
- Volume
- 58
- Issue
- 2
- Pages
- 401-407
- ISSN
- 0305-7453 (ISSN-L)
- 1460-2091
- OpenAlex
- W2130752053
- Cited by
- 598
- References
- 30
- FWCI
- 25.99
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.